Skip to main content
. 2020 Nov 20;7:592777. doi: 10.3389/fnut.2020.592777

Table 6.

Adjusted odds ratios of hyperuricemia among participants associated with supplemental vitamin D intake.

Supplemental vitamin D intake (mcg/day) p for trend
Non-user <15 15–100 ≥100
(n = 6109) (n = 1046) (n = 723) (n = 49)
Male (n = 7,927) Model 1a Reference 0.76 (0.64, 0.90) 0.87 (0.72, 1.06) 0.61 (0.28, 1.30) 0.0068
Model 2b Reference 0.73 (0.62, 0.87) 0.83 (0.69, 1.01) 0.58 (0.27, 1.25) 0.0013
Model 3c Reference 0.77 (0.65, 0.92) 0.89 (0.73, 1.09) 0.65 (0.30, 1.43) 0.0268
Non-user <15 15–100 ≥100
(n = 5,341) (n = 1,004) (n = 1,350) (n = 101)
Female (n = 7,796) Model 1a Reference 0.83 (0.70, 0.98) 0.82 (0.70, 0.95) 0.68 (0.42, 1.10) 0.0100
Model 2b Reference 0.84 (0.71, 1.00) 0.85 (0.73, 0.99) 0.71 (0.43, 1.16) 0.0089
Model 3c Reference 0.95 (0.79, 1.14) 0.89 (0.75, 1.05) 0.68 (0.41, 1.16) 0.0804
a

Adjusted for age, race/ethnicity;

b

adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status and diabetes status;

c

adjusted for age, race/ethnicity, smoking status, drinking status, hypertension status, diabetes status, creatinine, STC, glucose, BMI, HDL-C, STG, serum calcium, magnesium intake, zinc intake, fiber intake.